pregnancy and childbirth

June 9, 2022

Filling multiple opioid prescriptions after childbirth associated with maternal death risk

In a new study led by Vanderbilt University Medical Center researchers, women who filled two or more prescriptions for opioids after childbirth faced a 46% greater risk of death than women who did not.

By Jake Lowary
March 28, 2022

Rheumatoid arthritis: special deliveries

Birth outcomes including postpartum infection and blood transfusion were similar in women with and without rheumatoid arthritis, and continued use of disease-modifying antirheumatic drugs and biologics is recommended to limit steroid exposure.

By Bill Snyder
February 28, 2022

Invasive strep can defy zinc toxicity

Vanderbilt researchers find that invasive Group B Streptococcus strains, a significant risk to pregnant patients and infants, can grow in presence of toxic zinc levels.

By VUMC News and Communications
November 15, 2021

Common questions about COVID vaccine and pregnancy

By Nancy Humphrey
October 29, 2021

HCV infection among pregnant people increasing

By Emily Stembridge
September 30, 2021

Fibroids and preterm birth

In a large, prospective study, Vanderbilt researchers found no association between fibroids and any clinical subtype of preterm birth, supporting a reconsideration of the impression that fibroids increase preterm birth risk.

By Emily Stembridge
September 17, 2021

Grant creates center for maternal, pediatric precision therapeutics

Vanderbilt University Medical Center has been awarded a five-year, $6 million grant from the National Institutes of Health to serve as a center of excellence for Maternal and Pediatric Precision in Therapeutics.
By Christina Echegaray
September 1, 2021

Alarming number of pregnant COVID-19 patients hospitalized in August

Vanderbilt University Hospital treated 39 pregnant patients hospitalized with active COVID-19 infections in August, 10 of whom were admitted to the intensive care unit (ICU).
By Emily Stembridge
August 12, 2021

VUMC expands programming in effort to help pregnant and postpartum women, infants in opioid crisis

A newly created program at Vanderbilt University Medical Center is aiming to address the increasing toll the opioid crisis is having on pregnant and postpartum women and their infants.
By Jessica Pasley
August 2, 2021

VUMC sees increase of COVID-19 in pregnant patients

Physicians at Vanderbilt University Medical Center (VUMC) have recently noticed an increase in pregnant patients ill with COVID-19. These cases are especially concerning due an increased risk of hospitalization, ICU admission, need for mechanical ventilation and ventilatory support, and increased risk of death in pregnant patients with COVID-19 compared to non-pregnant patients.
By Emily Stembridge
June 3, 2021

‘Secret shopper’ study sheds light on barriers to opioid treatment for women

After a 2020 Vanderbilt University Medical Center study showed women have a difficult time accessing treatment for opioid use disorder (OUD), investigators analyzed comments received from the study’s participants to further shed light on barriers to care, which included everything from long on-hold times to difficult interactions with clinic receptionists during phone calls seeking appointments.
By Jill Clendening
September 8, 2020

Fibroids and birth outcomes

Women with three or more uterine fibroids — non-cancerous growths — during pregnancy are more likely to have infants with reduced birthweight and may need additional surveillance.
By Leigh MacMillan
August 14, 2020

Study finds patients’ access to opioid treatment cumbersome

Women are having a difficult time getting into treatment for opioid addictions, according to a Vanderbilt University Medical Center study published today in JAMA Open.
By Craig Boerner
1 2 3 4 … 6